"Defects in Pyk2 suppress Kawasaki Disease-like experimental vasculitis presumably through CXCL9- and CXCL10-dependent interference with neo-angiogenesis. Since Pyk2-KO mice show no life-threatening phenotype Pyk2 may be a promising therapeutic molecular target for KD."xsd:string